Jill M Wecht Selected Research

Quadriplegia (Spastic Quadriplegia)

6/2015	Prevalence of abnormal systemic hemodynamics in veterans with and without spinal cord injury.
5/2015	Biomarkers of inflammation in persons with chronic tetraplegia.
11/2011	Orthostatic effects of midodrine versus L-NAME on cerebral blood flow and the renin-angiotensin-aldosterone system in tetraplegia.
9/2010	Effects of midodrine hydrochloride on blood pressure and cerebral blood flow during orthostasis in persons with chronic tetraplegia.
6/2010	Exhaled nitric oxide levels are elevated in persons with tetraplegia and comparable to that in mild asthmatics.
8/2009	Orthostatic responses to nitric oxide synthase inhibition in persons with tetraplegia.
2/2009	Effect of hypotensive challenge on systemic hemodynamics and cerebral blood flow in persons with tetraplegia.
1/2008	Direct and reflexive effects of nitric oxide synthase inhibition on blood pressure.
1/2007	Normalization of supine blood pressure after nitric oxide synthase inhibition in persons with tetraplegia.
1/2005	Partial angiotensin-converting enzyme inhibition during acute orthostatic stress in persons with tetraplegia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jill M Wecht Research Topics

Disease

10	Quadriplegia (Spastic Quadriplegia) 06/2015 - 01/2005
8	Orthostatic Hypotension (Postural Hypotension) 01/2021 - 08/2009
8	Spinal Cord Injuries (Spinal Cord Injury) 02/2016 - 01/2004
3	Dizziness (Lightheadedness) 02/2016 - 01/2005
3	Hypertension (High Blood Pressure) 02/2016 - 09/2013
3	Hypotension (Low Blood Pressure) 06/2015 - 09/2010
2	Autonomic Dysreflexia 01/2017 - 09/2013
2	Asthma (Bronchial Asthma) 05/2015 - 06/2010
2	Paralysis (Palsy) 01/2007 - 07/2006
1	Neuralgia (Stump Neuralgia) 01/2017
1	Fatigue 02/2016
1	Inflammation (Inflammations) 05/2015
1	Tachycardia (Tachyarrhythmias) 09/2013
1	Bradycardia 09/2013
1	Insulin Resistance 01/2012
1	Dyslipidemias (Dyslipidemia) 01/2012
1	Paraplegia (Spastic Paraplegia) 07/2006
1	Type 2 Diabetes Mellitus (MODY) 01/2005
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2005

Drug/Important Bio-Agent (IBA)

5	hydroxide ionIBA 12/2017 - 09/2013
5	arginine methyl esterIBA 02/2016 - 01/2007
5	NG-Nitroarginine Methyl Ester (L-NAME)IBA 02/2016 - 01/2007
3	Midodrine (Midon)FDA LinkGeneric 02/2016 - 09/2010
3	Nitric Oxide Synthase (NO Synthase)IBA 08/2009 - 01/2007
2	Testosterone (Sustanon)FDA Link 01/2013 - 01/2011
2	ReninIBA 08/2009 - 01/2005
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 02/2009 - 01/2005
1	Antidepressive Agents (Antidepressants)IBA 01/2017
1	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 06/2015
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 06/2015
1	Pharmaceutical PreparationsIBA 06/2015
1	Antihypertensive Agents (Antihypertensives)IBA 06/2015
1	Bronchodilator Agents (Bronchodilators)IBA 05/2015
1	Biomarkers (Surrogate Marker)IBA 05/2015
1	DroxidopaIBA 10/2013
1	CarbohydratesIBA 01/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2010
1	AldosteroneIBA 08/2009
1	Enalaprilat (Vasotec)FDA LinkGeneric 02/2009
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2008
1	BuffersIBA 01/2008
1	Saline SolutionIBA 01/2008
1	SuspensionsIBA 01/2007
1	Pamidronate (Aredia)FDA LinkGeneric 05/2005
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2005
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2004
1	Neostigmine (Neostigmine Bromide)IBA 01/2004

Therapy/Procedure

1	Activities of Daily Living (ADL) 01/2021
1	Therapeutics 01/2013
1	Catheters 08/2009
1	Sympathectomy (Sympathectomies) 07/2006